CG
FLXN

Cutler Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Cutler Group’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,400
Closed -$5K – 5025
2018
Q4 		$5K Buy
+1,400
New +$21.9K ﹤0.01% 2972
2018
Q2 		– Sell
-17,800
Closed -$54K – 5168
2018
Q1 		$54K Buy
17,800
+2,100
+13% +$51.3K ﹤0.01% 1618
2017
Q4 		$11K Sell
15,700
-8,500
-35% -$208K ﹤0.01% 3078
2017
Q3 		$42K Buy
24,200
+1,900
+9% +$44.7K ﹤0.01% 2410
2017
Q2 		$66K Buy
22,300
+2,800
+14% +$58.3K ﹤0.01% 2217
2017
Q1 		$15K Buy
19,500
+14,800
+315% +$302K ﹤0.01% 3668
2016
Q4 		$10K Sell
4,700
-3,400
-42% -$65K ﹤0.01% 4255
2016
Q3 		$13K Buy
8,100
+7,100
+710% +$120K ﹤0.01% 3939
2016
Q2 		$3K Buy
+1,000
New +$12.6K ﹤0.01% 5484

Other funds holding FLXN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Cutler Group's FLXN Position: Q4 2020 in Review

Cutler Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2020, closing a stake of 49 shares.

Cutler Group first reported a position in FLXN in Q4 2015 and held it in 16 quarters. The position peaked at $393K in Q1 2018. 141 funds tracked by Wall St. Rank hold FLXN as of Q4 2020.

  • Cutler Group reported no remaining Flexion Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Cutler Group sold 49 Flexion Therapeutics, Inc. shares in Q4 2020.
  • Cutler Group first reported a position in Flexion Therapeutics, Inc. in Q4 2015 and held it in 16 quarters.
  • Cutler Group's Flexion Therapeutics, Inc. position peaked at $393K in Q1 2018.
  • 141 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.